EPH Receptor A5 Protein (EPHA5) (AA 26-573) (His tag)
-
- Target See all EPH Receptor A5 (EPHA5) Proteins
- EPH Receptor A5 (EPHA5)
- Protein Type
- Recombinant
- Protein Characteristics
- AA 26-573
-
Origin
- Human
-
Source
- HEK-293 Cells
- Purification tag / Conjugate
- This EPH Receptor A5 protein is labelled with His tag.
- Purpose
- Human EPHA5 Protein
- Sequence
- Ala26-Pro573
- Characteristics
- Recombinant Human EPHA5 Protein is expressed from HEK293 with His tag at the C-Terminus.It contains Ala26-Pro573.
- Purity
- > 95 % as determined by Tris-Bis PAGE,> 95 % as determined by HPLC
- Sterility
- 0.22 μm filtered
- Endotoxin Level
- Less than 1EU per μg by the LAL method.
-
-
- Restrictions
- For Research Use only
-
- Format
- Lyophilized
- Reconstitution
- Centrifuge the tube before opening. Reconstituting to a concentration more than 100 μg/mL is recommended. Dissolve the lyophilized protein in distilled water.
- Buffer
- Lyophilized from 0.22μm filtered solution in PBS ( pH 7.4). Normally 8 % trehalose is added as protectant before lyophilization.
- Storage
- -20 °C,-80 °C
- Storage Comment
- -20 to -80°C for 12 months as supplied from date of receipt.,-80°C for 3-6 months after reconstitution.,2-8°C for 2-7 days after reconstitution.,Recommend to aliquot the protein into smaller quantities for optimal storage. Please minimize freeze-thaw cycles.
- Expiry Date
- 12 months
-
- Target
- EPH Receptor A5 (EPHA5)
- Alternative Name
- EPHA5 (EPHA5 Products)
- Background
- Ephrin type-A receptor 5 (EphA5) expression was detected in all non-tumor gastric epithelia but was differentially expressed among gastric cancer samples. EphA5 is differentially expressed in gastric cancer. EphA5 may therefore be a potential therapeutic target and may have clinical utility as a marker for lymph node metastasis in gastric cancer.
- Molecular Weight
- 61.9 kDa. Due to glycosylation, the protein migrates to 68-80 kDa based on Tris-Bis PAGE result.
- Pathways
- RTK Signaling
-